BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 5900960)

  • 21. The copper connection.
    Linn FH; van Erpecum KJ; Klomp LW; Houwen RH
    Eur J Neurol; 2009 Oct; 16(10):1073-4. PubMed ID: 19566898
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hepatolenticular degeneration and hepatocerebral syndromes].
    Martynov IuS; Malkova EV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(1):53-7. PubMed ID: 4747508
    [No Abstract]   [Full Text] [Related]  

  • 23. The biochemistry of copper.
    Frieden E
    Sci Am; 1968 May; 218(5):103-14. PubMed ID: 4297207
    [No Abstract]   [Full Text] [Related]  

  • 24. Liver copper in health and disease.
    Epstein O
    Postgrad Med J; 1983; 59 Suppl 4():88-94. PubMed ID: 6647221
    [No Abstract]   [Full Text] [Related]  

  • 25. Impaired hepatic copper homeostasis in Long-Evans Cinnamon rats: reduced biliary excretion of copper.
    Suzuki M; Aoki T
    Pediatr Res; 1994 May; 35(5):598-601. PubMed ID: 8065844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Copper in childhood liver disease. A histologic, histochemical, and chemical survey.
    Reed GB; Butt EM; Landing BH
    Arch Pathol; 1972 Mar; 93(3):249-55. PubMed ID: 4551497
    [No Abstract]   [Full Text] [Related]  

  • 27. Copper and ceruloplasmin metabolism in the LEC rat, an animal model for Wilson disease.
    Kodama H; Murata Y; Mochizuki D; Abe T
    J Inherit Metab Dis; 1998 Jun; 21(3):203-6. PubMed ID: 9686357
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of caeruloplasmin in copper excretion.
    Chowrimootoo GF; Seymour CA
    Biochem Soc Trans; 1994 May; 22(2):190S. PubMed ID: 7958253
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ceruloplasmin in serum in liver diseases].
    Hauftová D; Slavícek J
    Cesk Gastroenterol Vyz; 1966 Apr; 20(3):145-53. PubMed ID: 5934909
    [No Abstract]   [Full Text] [Related]  

  • 30. Investigations by the use of radioactive copper (64Cu) in chronic liver diseases.
    Wysocki K; Owczarek L; Górski S; Kurnatowska A
    Pol Med J; 1969; 8(1):43-9. PubMed ID: 5782169
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hepatoportal encephalomyelopathy].
    Bogolepov NK; Martynov IuS; Malkova EV; Tsivil'ko VS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(4):496-506. PubMed ID: 5497105
    [No Abstract]   [Full Text] [Related]  

  • 32. A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives.
    Prasad R; Kaur G; Walia BN
    Biol Trace Elem Res; 1998 Nov; 65(2):153-65. PubMed ID: 9881519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histochemical copper, copper associated protein & immunohistochemical ceruloplasmin in adult liver biopsy.
    Mehrotra R
    Indian J Med Res; 1986 Apr; 83():391-400. PubMed ID: 3522417
    [No Abstract]   [Full Text] [Related]  

  • 34. Diagnosis of Wilson's disease presenting as fulminant hepatic failure.
    McCullough AJ; Fleming CR; Thistle JL; Baldus WP; Ludwig J; McCall JT; Dickson ER
    Gastroenterology; 1983 Jan; 84(1):161-7. PubMed ID: 6847842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Wilson's disease. I].
    Sánchez Rodríquez A; González Macias J; Diez Jarilla JL; Suquia Múgica B; de Portugal Alvarez J
    Rev Esp Enferm Apar Dig; 1982 Jul; 62(1):68-73. PubMed ID: 6753060
    [No Abstract]   [Full Text] [Related]  

  • 36. Abnormalities in copper metabolism and disturbances in the synthesis of collagen and elastin.
    Kivirikko KI; Peltonen L
    Med Biol; 1982 Apr; 60(2):45-8. PubMed ID: 6124662
    [No Abstract]   [Full Text] [Related]  

  • 37. Excess copper chelating therapy for Wilson disease induces anemia and liver dysfunction.
    Harada M; Miyagawa K; Honma Y; Hiura M; Shibata M; Matsuhashi T; Abe S; Harada R; Tabaru A
    Intern Med; 2011; 50(14):1461-4. PubMed ID: 21757830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Molecular defect of ceruloplasmin synthesis and maturation in Wilson-Konovalov disease].
    Puchkova LV; Vakharlovskiĭ VG; Gaĭtskhoki VS; Monakhov NK; Shvartsman AL
    Genetika; 1982 May; 18(5):703-12. PubMed ID: 7201432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Metabolic capacity of the liver for drugs in hepatobiliary patients].
    González Macias J; Herreros Fernández V; De Castro Del Pozo S
    Rev Clin Esp; 1975 Jan; 136(2):123-30. PubMed ID: 1121588
    [No Abstract]   [Full Text] [Related]  

  • 40. Copper balance and ceruloplasmin in chronic hepatitis in a Wilson disease animal model, LEC rats.
    Komatsu Y; Ogra Y; Suzuki KT
    Arch Toxicol; 2002 Sep; 76(9):502-8. PubMed ID: 12242607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.